Objectives: Endothelin-1 (ET-1), plays an important role in the pathophysiology of CHF and the pulmonary endothelium is an early hemodynamic target in diastolic left ventricular dysfunction. Therefore we hypothesized that the lung is a main source of humoral endothelin in CHF and that its secretion is proportional to the degree of heart failure. Methods and results: We used rats with coronary artery ligation as an experimental model of either compensated or decompensated heart failure, depending on infarct size. Reverse transcriptase polymerase chain reaction (RT-PCR) revealed that in the lung, the expression of preproET-1 mRNA was higher in decompensated HF than in control and compensated HF rats (P,0.001). Run-on assay demonstrated that ET-1 overexpression is regulated at a transcriptional level (P,0.01). In contrast, there was no change in ET-1 mRNA expression in aortae, left ventricular myocardium and skeletal muscle. The expression of endothelin-converting enzyme (ECE)-1 mRNA was not modified and the expression of ET receptor mRNA in the congestive lung was significantly lower than in control and compensated HF rats (P,0.0001), while the B expression of ET receptor mRNA did not differ between groups. The lung and plasma ET-1 peptide levels were respectively 4.2 and 9 A fold higher in the rats with decompensated HF than in control rats (P,0.05; P,0.0001). Organoculture experiments showed that the lung ET-1 peptide secretion level in rats with decompensated HF was higher than that in control rats (P,0.01). In contrast, there was no change in ET-1 peptide secretion by the left ventricular myocardium and skeletal muscle. In plasma of rats with decompensated HF, the rate of bigET-1 conversion to ET-1 was 22%. ET-1 peptide was also present in the pleural effusion of decompensated heart failure. Plasma ET-1 concentration was significantly correlated with upstream markers of left ventricular diastolic dysfunction, with the expression of preproET-1 mRNA in the lung, with lung and pleural ET-1 concentration and with the expression ratio of ET-1 / ET B receptor mRNA. Conclusion: Taken together, these data suggest that overexpression of ET-1 and down-regulation of ET receptors in the B lung are determinants of circulating endothelin in CHF. As a corollary, increased plasma endothelin may provide evidence of pulmonary endothelial dysfunction in CHF.
Introduction
early in the pulmonary circulation upstream to the dysfunctional left ventricle [2] .
Left ventricular dysfunction has upstream hemodynamic
The lung is an endothelium-rich organ in which it is consequences on pulmonary endothelial function in early possible to evaluate endothelial secretion in plasma and the diastole [1, 2] . For example we have reported a downreguendothelial response to circulating agents. For example, we lation of the expression of angiotensin converting enzyme have already shown that the pulmonary endothelium which correlates with the degree of heart failure in the responds to plasma atrial natriuretic peptide by secreting model of experimental myocardial infarction in rats [3] . plasma cyclic GMP in experimental congestive heart Similarly, constitutive eNOS expression also decreased failure [4] . Endothelin-1 (ET-1) is a peptide constitutively secreted by endothelial cells [5] . ET-1 is initially synthesized as a mM and 200 mM, respectively. These samples were large inactive precursor protein called preproET-1, which centrifuged for 10 min at 3000 g, the supernatants stored at is first cleaved at two pairs of basic amino acids to 2208C. Pleural effusion volume was measured. The heart generate bigET-1. It is then cleaved by endothelin-convertwas excised and weighed. The left ventricle was then ing enzyme (ECE) to produce the active peptide ET-1.
separated from the rest of the heart (i.e. right ventricle and Nevertheless the relative importance of the intracellular the two atria) and weighed. Lungs, thoracic aortae, left versus the extracellular conversion of bigET-1 remains ventricular myocardium and tibialis anterior skeletal musunclear. Circulating ET-1 levels are elevated in an excle were rapidly excised in 37 rats, rinsed in cold phosperimental model of heart failure [6] as well as in humans phate-buffered saline, frozen in liquid nitrogen, and stored [7] . Moreover, blockade of the endothelin system has a at 2808C. beneficial effect on survival rate and hemodynamic parameters in heart failure [8] [9] [10] . Nevertheless, the hemo-2.2. Infarct size determination dynamic stimulus for the elevation of plasma ET-1 concentration in congestive heart failure remains to be defined.
Myocardial infarction (MI) size was measured in 34 rats The pulmonary vascular bed is an important site for by use of techniques previously described by Chien et al. plasma production of ET-1 in congestive heart failure [11] . [3, 15] . The left ventricle was opened via an incision along Therefore we hypothesized that the lung is a main source the septum from base to apex so that the left ventricular of endothelial ET-1 expression and secretion in response to tissue could be pressed flat. The circumference of the left ventricular diastolic dysfunction.
entire flat left ventricle and the observable infarcted area, To demonstrate this point, we have evaluated the as judged from both epicardial and endocardial sides, were expression of the different components of the endothelin outlined on a transparent plastic sheet. The difference in system, bigET-1, ET-1, ECE-1, ET and ET receptors in weight between the two marked areas on the sheet was A B lungs in comparison with aorta, left ventricular myocarused to determine the size of MI and was expressed as a dium and skeletal muscle, of rats with experimentallypercentage of left ventricular surface area. The degree of induced congestive heart failure. We observed a transcripcongestive heart failure in the MI group was defined tional upregulation of the ET-1 gene, a downregulation of according to one major criterion, the presence of pleural ET endothelial receptor expression and an increase in effusion corresponding to an increased heart weight-left B ET-1 secretion in the lungs, the presence of ET-1 in the ventricle weight index. pleural effusion, and a correlation between all these different parameters and the degree of heart failure. In 2.3. Run-on assay contrast, these parameters were not influenced by the degree of heart failure in other tissues.
The run-on assay permits the study of the transcription rate of a given gene in vitro. This transcriptional activity is dependent on proteic transcription factors present in the 2. Methods nucleus. For this purpose, lung nuclei were isolated on ice at 48C as described by Boggaram et al. [16] . In vitro 7 2.1. Experimental design transcriptions were carried out in the presence of 4310 32 isolated nuclei and (a-P)CTP, as described by Mak et al. Normotensive male Wistar rats (Charles River, France) [17] with slight modifications. On the other hand, a large weighing 300 g were used. Left ventricular infarction was amount (10 mg) of cDNA encoding for preproET-1 and produced by ligation of the left coronary artery under ether GAPDH amplified in Bluescript KS plasmids and pGEM anesthesia as described by Fishbein et al. [12, 13] . The left plasmids respectively, were denatured and immobilized on descending anterior coronary artery was ligated proximally a nylon filter (Hybond-N, Amersham). Empty Bluescript to obtain moderate or large infarcts leading to compensated KS and pGEM plasmids were used as negative controls. or decompensated heart failure [14] . Control rats were Slot blots were then hybridized with equivalent amounts of 6 sham-operated using a similar procedure without coronary radioactive RNA (7310 cpm) obtained from lungs of artery ligation. The investigation conforms with the Guide myocardial infarction or control rats. After hybridization, for the Care and Use of Laboratory Animals published by the blots were washed and exposed to Kodak Biomax MS the US National Institutes of Health (NIH Publication No.
film with an intensifying screen at 2808C for 7 days. 85 -23, revised 1996) .
Therefore the intensity of the band was proportional to the The experimental period was 3 months. The animals in vitro transcription rate giving evidence of the activity of were examined twice weekly. At the end of the experimenthe preproET-1 gene. tal protocol, rats were sacrificed. Blood and pleural effusion samples were collected in prechilled 10 ml tubes 2. skeletal muscle and aortae using the method described by The anti-ET-1 antibody showed 100% specificity for Chomczynski and Sacchi [18] . After mixing by inversion, these samples were centrifuged RNA, 1 mg of total skeletal muscle and 600 ng of total for 20 min at 2000 g at 48C. The supernatants were dried aorta RNA were primed with 1 mg oligo(dT) (Pharmacia down in a centrifugal evaporator. The pellets were reBiotech) and reverse transcribed in the presence of suspended in 0.25 ml of sample diluent. Then 100 ml of Moloney murine leukemia virus reverse transcriptase (Mthis sample extract were used to measure ET-1 levels. MLV reverse transcriptase) (GIBCO). The cDNA was Pleural effusion ET-1 levels were only measured in 8 rats amplified by PCR with the use of specific oligonucleotide since the immunoassay used required a minimal volume of primers for rat preproET-1 [5] ET receptor and GAPDH [20] . The sequences of the heterogeneous (0.4 to 15.9 ml) of which 10 samples B oligonucleotides are summarized in Table 1 . Doublecontained less than 2 ml. stranded cDNAs were synthesized and amplified using Lung ET-1 tissue was extracted as previously described 1.25 U Taq polymerase (GIBCO), 20 mM TrisHCl (pH [21] . Briefly, 100 mg of lung were homogenized in 4 M 8.0), 50 mM KCl, 0.2 mM of dNTP, 10 pmol of each of guanidium thiocyanate / 0.1% trifluoroacetic acid on ice. the primers except for GAPDH where primers were used at An aliquot was taken for protein measurement (Bio-Rad, PCR fragments were analyzed by 8% PAGE and were As ET-1 is secreted, approximatively 1 g of lung, left visualized by ethidium bromide staining. Bands were cut ventricle and skeletal muscle were incubated in 1 ml of out, dissolved in periodic acid (25 mM), and counted with medium consisting of DMEM supplemented with 20 mM the use of a RackBeta liquid scintillation counter. PCR HEPES (Boerhinger Mannheim), 2 mM L-glutamine, 50 amplification was verified to be exponential, and the UI / ml penicillin, 50 mg / ml streptomycin, and 0.125 mg amplification products were proportional to sample input. amphotericin B (Sigma, St Louis, MO) for 48 h. ET-1 PreproET-1,ECE-1, ET and ET receptors mRNA exlevels in the culture medium were measured using a Plasma, pleural and lung ET-1 levels were measured To measure bigET-1 levels, a stably transfected CHO using a commercial ELISA kit (Parameter, R & D cell line expressing a soluble form of human ECE (sECE) Systems, Minneapolis, USA).
[22] was used as source of endothelin converting enzyme activity. Partial purification of sECE-1 from the con-(moderate myocardial infarction) were studied for determiditioned medium of CHO / sECE cells was performed as nation of heart failure graduation. There was no significant described [22] . The integrity of the enzymatic preparation difference in body weight between rats with myocardial was monitored by analyzing the enzymatic conversion of infarction and control rats (Table 2 ). Both the total heart bigET-1 into ET-1 peptide carried out in 100 ml 50 mM weight and the ratio of total heart weight to body weight HEPES buffer (pH 6.8), 150 mM NaCl, 0.1 mM ZnCl and (heart weight index) were significantly increased in the 2 0.1% BSA at different enzyme and bigET-1 concentradecompensated as compared compensated and control rats tions. Plasma and pleural samples were fractionated in 1 (F530, P,0.0001) ( Table 2 ). The absolute weight of the ml aliquots. One ml of heparinized plasma was suppart of the myocardium hemodynamically upstream to the plemented with 0.1 mM ZnCl , 20 mM 2-[N-Morpholino]-infarcted left ventricle (i.e. heart weight-left ventricle 2 ethanesulfonic acid (pH 5.5) and 200 mM PMSF and weight) and its ratio to body weight (heart weight-left incubated at 378C in the presence of soluble ECE for 30 ventricle weight index) were also significantly increased in min. The reaction was stopped by adding 5 ml of 0,5 M decompensated HF rats (F525, P,0.0001) ( Table 2) . EDTA, the sample concentrated as describe above and then Infarct size averaged 2461.6% of the left ventricle area in subjected to a commercial ELISA kit to quantify ET-1 rats with compensated HF and 4161.6% in rats with produced by the enzymatic conversion of bigET-1 into decompensated HF (F5179, P,0.0001). The heart ET-1 peptide. Specificity of the conversion was monitored weight-left ventricle weight was related to infarct size by preincubation of the enzyme with 100 mM phosphor-(r50.88, F5114.2, P,0.0001). All rats assigned to the amidon, an ECE inhibitor prior to the incubation with decompensated stage presented pleural effusion. plasma samples. Endogenous ET-1 was quantified from plasma or pleural effusion not submitted to ECE incuba-3.2. Expression of endothelin system mRNAs tion. All determinations were performed in duplicate.
The expression of preproET-1 mRNA, ECE-1 mRNA, 2.8. Statistical analysis ET and ET receptor mRNAs in lung from rats with A B infarct and from controls was evaluated by comparative Results are expressed as mean6S.E.M. The difference RT-PCR. The expression of preproET-1 mRNA was in each biological parameter (in lung, aorta or plasma) was significantly increased in the lungs of the rats with evaluated by a one-way ANOVA for the increase of each decompensated HF (Fig. 1A) . The ratio of the levels of variable measured. ANOVA was followed by Scheffe's F preproET-1 mRNA to GAPDH mRNA was significantly test to compare the effect of different pathophysiological increased from 1.1760.07 in the sham-operated group and conditions on these parameters. Regression curves and 1.1960 .04 in the compensated HF group to 1.6260.09 in correlation coefficients were obtained by the least-squares the decompensated HF group (P,0.0004). The lung method (Statview software). Statistical significance was preproET-1 mRNA expression was related to the degree of accepted for P,0.05. heart failure and was therefore positively correlated with the markers of severity: the heart weight-left ventricle weight (r50.48, F510, P,0.01) and the infarct size 3. Results (r50.61, F521.1, P,0.0001). In contrast, aortic, left ventricle and skeletal muscle expression of preproET-1 3.1. Heart parameters mRNA did not differ between decompensated and compensated HF and control rats (Fig. 1B) . A total of 18 rats with decompensated HF (severe Semi-quantitative RT-PCR showed a similar ECE-1 myocardial infarction) and nine with compensated HF expression in the lung of HF and control rats (1.2860.18 ET receptor mRNA did not differ between control and A HF rats (1.460.1 versus 1.3260.6) (Fig. 2) . In contrast, the expression of ET receptor mRNA in the lung was heart-left ventricle weight index (r520.85, F584.3, P, B significantly lower in rats with decompensated HF than in 0.0001) and the infarct size (r520.76, F544.9, P, compensated HF and control rats (F548, P,0.0001) . The 0.0001). expression of ET receptor mRNA was decreased four B fold in decompensated HF rats compared with control rats 3.3. Endothelin gene transcription (Fig. 2) . The ET receptor mRNA expression was nega-B tively correlated with the markers of HF severity: the To determine whether the increase in preproET-1 performed a nuclear run-on transcriptional assay (Fig. 3) . (Fig. 4C) (Fig. 4D) and with plasma ET-1 concentration 0.3760.035 pg / ml for control and 0.8460.28 pg / ml for (r50.7, F531, P,0.001) (Fig. 4A) . compensated HF rats. Plasma ET-1 level was significantly
The lung ET-1 peptide secretion level in rats with correlated with the heart-left ventricle weight index (r5 decompensated HF was significantly higher than that of 0.81, F579.4, P,0.0001) (Fig. 4B) , with the infarct size control rats (Table 3 ). In contrast, left ventricle and (r50.76, F548.5, P,0.0001), with the expression of skeletal muscle ET-1 peptide secretion levels did not differ preproET-1 mRNA in the lung (r50.72, F58 P,0.001), between groups. The lung ET-1 peptide secretion was with the pleural effusion ET-1 concentration (r50.77, correlated with heart weight (r50.63, F59.8, P,0.01). F510, P,0.05) and negatively with the expression of ET
The conversion rate of bigET-1 into ET-1 peptide was B receptor mRNA (r50.79, F555, P,0.0001). Plasma 2262.39% in plasma of decompensated HF rats. In view of the low level of circulating bigET-1, significant conversion could not be detected in the plasma of control and compensated HF rats. Similarly, no detectable conversion could be measured in the pleural effusions.
Discussion
Endothelin is a peptide constitutively secreted by the endothelial cells [5] , circulating at a low level because of its high affinity for its endothelial receptor which functions as one of the main clearance mechanisms for the circulating peptide [23] .
The lung is an organ particularly rich in endothelium [24] and pulmonary endothelium is an early hemodynamic target upstream to the diastolic left ventricular dysfunction [2] due to myocardial infarction in rats [14] . Pulmonary endothelial dysfunction is mainly due to a chronic decrease in shear stress as a consequence of the diastolic pressuredependent increase in pulmonary vascular dimensions associated with a decrease in blood flow [2] . Therefore we tested the hypothesis that endothelin expression is upregulated in the lung in experimental heart failure and could be a main source of humoral endothelin in congestive heart failure.
The present study shows that the ET-1 gene is overexpressed in the lungs of rats in HF, and this expression correlates with the degree of heart failure, suggesting an interdependency between hemodynamic disturbance and endothelin expression in the lung. Run-on assay demonstrated that this overexpression is transcriptionally regulated. The presence of ET-1 in the pleural effusion and in heart failure. Therefore the secreted peptide diffused absence of its upregulation in the kidney. The present data, from the interstitial compartment to the pleural liquid.
as in a dog model of heart failure [27] extend them to These data have been confirmed by the assessment of in show: first, that this overexpression is transcriptionally vitro secretion of ET-1 by lung tissues. Previously pubregulated probably by hemodynamic forces in a tissue lished data have already shown an overexpression of ET-1 submitted to low shear stress in vivo [2] and second, that in pulmonary endothelium of HF in rats [25, 26] and the this overexpression is probably a main source of the peptide present in the pleural effusion and the plasma.
myocardial tissue rather than a systemic one. In the present Therefore all these parameters, lung, plasma and pleural study, we did not observe any overexpression and over-ET-1 concentration, and lung ET-1 mRNA are all corresecretion of ET-1 from cardiac muscle in decompensated lated with each other and also with the degree of heart heart failure as compared to compensated and controls. failure.
These results are supported by human data [7] showing a The regulation of endothelial endothelin expression by correlation between plasma endothelin concentrations and shear stress has been modeled in vitro by several groups hemodynamic perturbations and an absence of relation to [28, 29] leading to conflicting results. Morita et al. showed myocardial peptide secretion in coronary plasma effluent in that shear-stress induced endothelin-1 gene expression in human congestive heart failure. Serneri et al. [41] recently cultured endothelial cells [30] whereas Malek et al. [28, 31] showed a complete dissociation between plasma level of reported a down-regulation of endothelin expression in ET-1 and myocardial overexpression of the endothelin endothelial cells submitted to shear stress. Our in vivo data system in different forms of congestive heart failure. confirm the latter in vitro results, showing that left Similarly, Stangl et al. [42] recently demonstrated that the ventricular dysfunction induced a decrease in shear stress lung acted as producer and the heart and the periphery in the pulmonary circulation [2] which was associated with acted as consumers of elevated circulating endothelin in a decrease in endothelial NO synthase function [1] and human congestive heart failure. expression [2] and an increase in endothelin expression in
In order to evaluate whether humoral bigET-1 conthe lung of animals with congestive heart failure.
centration could be a more valuable marker in congestive Because endothelin is a peptide secreted by the endoheart failure than ET-1 itself, we have measured the thelium into the tissue interstitium and the plasma, the conversion rate of bigET-1 to ET-1 in plasma and pleural quantity of extracellular peptide in plasma and pleural effusion using a soluble form of human ECE. In view of effusion correlates better with the degree of heart failure the very low level of circulating endothelin in control and than with the tissue concentration in the lung. The downcompensated HF rats and the lack of sensitivity of the regulation of ET receptor mRNA also suggested that the assay on heparinized plasma, we could not detect any B endothelium is a main source of plasma endothelin and conversion in these groups. In contrast, in decompensated that circulating endothelin interacted mainly with its HF rats, in which the plasma endothelin concentration was endothelial receptor. It has been shown that ET receptors higher, we could detect a conversion rate around 20%.
B are mainly expressed in the endothelium [32] . Endothelial These data suggest that ECE activity is not a rate limiting ET receptors play a predominant role in the physiological step in ET-1 production in the plasma endothelium com-B clearance of extracellular endothelin-1 in vitro [33] and of partment and confirm our observations that endothelial cell plasma circulating endothelin-1 in vivo [34, 35] . Moreover, cultures are able to convert all the bigET-1 [43] and those the level of ET receptor mRNA was down-regulated by reported after bigET-1 intravenous infusion in vivo [44] .
B endothelins and this phenomenon appears to be related to Similarly, we could not detect any bigET-1 conversion in an endothelin-induced decrease in intracellular stability of pleural effusion, suggesting that ECE activity is not a rate mRNA molecules [36] . It has been shown that reduced limiting step in ET-1 production in the lung [44] . Therepulmonary clearance of endothelin-1, via the down-regulafore, it appears that the measurement of plasma bigET-1 is tion of ET receptors [37] contributed to the increase in not more relevant than the measurement of ET-1 itself in B circulating levels of the peptide in heart failure [38] . Our experimental congestive heart failure. Nevertheless, to data confirm the results of these previous studies, showing provide a definitive answer to the question, the developa clear negative correlation between plasma endothelin and ment of a specific direct immunoassay of bigET-1 in rat is lung ET receptor mRNA expression. This down-regularequired as has been already developed for the human form B tion was restricted to the ET receptor isoform, suggesting [45] .
B that the phenomenon was limited to the endothelium.
In conclusion, these data suggest that dysfunction of the Nevertheless, an extra-endothelial and extra-pulmonary pulmonary endothelium, including overexpression of the source of endothelin cannot be completely excluded. Sakai endothelin gene and down-regulation of the ET receptor, B and Oie et al. [6, 39] showed an overexpression of the ET-1 is probably a main source of plasma endothelin in exgene and an upregulation of ET-1 binding sites in the perimental congestive heart failure. As a corollary, an non-scarred myocardium of HF rats. Similar data have increase in circulating endothelin may provide evidence of been reported by Picard et al. [40] . But, in contrast with endothelial dysfunction in congestive heart failure. our observations in the lung, ET and ET receptor mRNA A B expression and ET-1 binding sites increased in parallel [6, 40] . Moreover in the study of Oie et al. [39] the
